Structural Basis for Medium-Chain Dehydrogenase/Reductase-Catalyzed Reductive Cyclization in Polycyclic Tetramate Macrolactam Biosynthesis
Journal of the American Chemical Society · 04.06.2025 · 147 (22) · 19253-19261
DOI: 10.1021/jacs.5c04971 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Chemical Society, online erschienen am 23.05.2025. Verfasst von Xiangqian Xie und 9 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Discovery and Utilization of Functional Components in Traditional Chinese Medicine, School of Pharmaceutical Sciences, Cheelo…. Hauptthemen laut MEDLINE: Oxidoreductases, Lactams, Macrocyclic, Lactams. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 25 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Shandong Province.
Abstract (Originalsprache)
Few enzymes are known to catalyze reductive cyclizations via nucleophile-mediated C-C bond formation. Medium-chain dehydrogenases/reductases (MDRs) typically function as dehydrogenases or reductases. However, a distinct subclass of MDRs involved in polycyclic tetramate macrolactam (PoTeM) biosynthesis catalyzes reductive cyclizations via hydride-mediated C-C bond formation. Here, we present the apo and substrate-bound structures of OX4 and CftD, two enzymes responsible for the third ring formation in PoTeMs biosynthesis. Structural and mutational analysis reveal a catalytic mechanism wherein OX4 initiates a NADPH-dependent 1,6-reduction, followed by cyclization to form the C11-C22 bond, water-mediated protonation of the C7-carbonyl oxygen, and a final tautomerization to produce the cyclized product. Precise substrate positioning and stabilization of the enolate intermediate by the conserved residue W260 are critical for catalysis. These findings represent the first structural and mechanistic understanding of this newly identified cyclase subgroup and offer promising new avenues for enzyme engineering and natural product biosynthesis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Discovery and Utilization of Functional Components in Traditional Chinese Medicine, School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, Jinan 250012, People's Rep…
- State Key Laboratory of Microbial Technology, Shandong University, Qingdao 266237, People's Republic of China.
- Department of Chemistry, University of Nebraska-Lincoln, Lincoln, Nebraska 68588, United States.
- School of Basic Medical Sciences, Cheeloo College of Medicine, Shandong University, Jinan 250012, People's Republic of China.
ORCID-Profile: Xiangqian Xie, Haoxin Wang, Yuemao Shen, Liangcheng Du, Deyu Zhu, Yaoyao Li
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Shandong Province
Zitieren
APA
Xie, X., Li, F., Mu, Y., Lu, M., Luo, J., Wang, H., Shen, Y., Du, L., Zhu, D., & Li, Y. (2025). Structural Basis for Medium-Chain Dehydrogenase/Reductase-Catalyzed Reductive Cyclization in Polycyclic Tetramate Macrolactam Biosynthesis. Journal of the American Chemical Society, 147(22), 19253-19261. https://doi.org/10.1021/jacs.5c04971
Vancouver
Xie X, Li F, Mu Y, Lu M, Luo J, Wang H, et al. Structural Basis for Medium-Chain Dehydrogenase/Reductase-Catalyzed Reductive Cyclization in Polycyclic Tetramate Macrolactam Biosynthesis. Journal of the American Chemical Society. 2025;147(22):19253-19261. doi:10.1021/jacs.5c04971
BibTeX
@article{Xie2025,
author = {Xie, Xiangqian and Li, Fan and Mu, Yanxin and Lu, Mengyao and Luo, Jie and Wang, Haoxin and Shen, Yuemao and Du, Liangcheng and Zhu, Deyu and Li, Yaoyao},
title = {Structural Basis for Medium-Chain Dehydrogenase/Reductase-Catalyzed Reductive Cyclization in Polycyclic Tetramate Macrolactam Biosynthesis},
journal = {Journal of the American Chemical Society},
year = {2025},
volume = {147},
number = {22},
pages = {19253--19261},
doi = {10.1021/jacs.5c04971}
}
EUVIMED